HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter J Malloy Selected Research

Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)

1/2014Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
10/2013Cell-autonomous regulation of brown fat identity gene UCP1 by unliganded vitamin D receptor.
4/2012The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3.
12/2011The role of vitamin D receptor mutations in the development of alopecia.
11/2011Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor.
1/2011Report of two unrelated patients with hereditary vitamin D resistant rickets due to the same novel mutation in the vitamin D receptor.
10/2009Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy.
4/2009Compound heterozygous mutations in the vitamin D receptor in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia.
8/2007Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions.
4/2007A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter J Malloy Research Topics

Disease

15Rickets (Rachitis)
01/2014 - 11/2002
13Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
01/2014 - 11/2002
9Alopecia (Baldness)
12/2011 - 11/2002
8Inborn Genetic Diseases (Disease, Hereditary)
02/2012 - 11/2002
6Hypocalcemia
01/2014 - 11/2002
5Prostatic Neoplasms (Prostate Cancer)
04/2009 - 05/2004
4Neoplasms (Cancer)
04/2009 - 05/2004
3Hypophosphatemia
01/2014 - 04/2009
3Secondary Hyperparathyroidism
01/2014 - 11/2002
2Hypophosphatemic Rickets
06/2010 - 01/2010
1Rare Diseases (Rare Disease)
12/2011
1Atrichia with Papular Lesions
08/2007

Drug/Important Bio-Agent (IBA)

17Calcitriol Receptors (Calcitriol Receptor)IBA
01/2014 - 11/2002
141,25-dihydroxyvitamin DIBA
01/2014 - 11/2002
4Vitamin DFDA LinkGeneric
01/2014 - 09/2005
4Proteins (Proteins, Gene)FDA Link
10/2013 - 02/2008
4Calcitriol (Calcijex)FDA LinkGeneric
01/2010 - 05/2004
3DNA (Deoxyribonucleic Acid)IBA
04/2012 - 01/2010
3LigandsIBA
04/2012 - 12/2002
3CalciumIBA
01/2011 - 05/2004
2Nonsense Codon (Nonsense Mutation)IBA
08/2010 - 12/2002
2Co-Repressor ProteinsIBA
11/2009 - 08/2007
2Insulin-Like Growth Factor Binding Protein 3IBA
02/2008 - 10/2006
2AndrogensIBA
02/2008 - 10/2006
2Insulin-Like PeptidesIBA
02/2008 - 10/2006
2Alkaline PhosphataseIBA
12/2002 - 11/2002
1Fatty Acids (Saturated Fatty Acids)IBA
10/2013
1Pyrimidine DimersIBA
04/2012
1Hormones (Hormone)IBA
01/2010
1ChromatinIBA
04/2009
1Anti-Mullerian HormoneIBA
04/2009
1Retinoid X Receptors (Retinoid X Receptor)IBA
04/2009
1Cholecalciferol (Vitamin D3)FDA Link
02/2009
1StaurosporineIBA
02/2009
1CaspasesIBA
02/2009
1Caspase 3 (Caspase-3)IBA
02/2009
1Phosphates (Orthophosphate)IBA
05/2004

Therapy/Procedure

1Therapeutics
10/2009